We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pioneering Brain Malformation Treatment in India Using Radiosurgery Technology

By HospiMedica International staff writers
Posted on 20 Oct 2009
A 17-year-old female with a complex arteriovenous malformation (AVM) of the brain has become the first person in India to be treated using an advanced and fast radiosurgery platform.

The technology involved in the therapy was the Novalis Tx radiosurgery platform system, developed by Varian Medical Systems, Inc. More...
(Palo Alto, CA, USA) and BrainLAB (Munich, German). Doctors at Kokilaben Dhirubhai Ambani Hospital (Mumbai, India) performed the pioneering stereotactic radiosurgery treatment in a single session that took just a few minutes to complete. "The patient's malformation, which was near the motor cortex on the right side of the brain, had been partially embolized and it was considered that no further treatment was possible,” said Dr. Ram K. Narain, the hospital's chief operating officer. "Following Novalis Tx radiosurgery treatment the patient's symptoms had alleviated considerably. She will now have an MRI [magnetic resonance imaging] scan every six months to monitor her progress. The medical team was very happy with her treatment.”

Arteriovenous malformations are abnormal connections between veins and arteries and are normally congenital and frequently inoperable. Bleeding from an AVM can be devastating, especially in the brain, where it can cause severe and often fatal strokes.

Dr. Narain reported that Kokilaben Hospital was proud to be the first in India to introduce the Novalis Tx radiosurgery platform clinically. "Image-guided, frameless, and noninvasive radiosurgery is very much today's innovation and tomorrow's radiosurgery technique of choice,” he said. "It offers a more patient-friendly alternative to conventional radiosurgery systems that require immobilization with a head ring that attaches to the skull. With this system, we can deliver a highly conformal and homogenous dose to irregularly shaped lesions in a single session, which was not achievable with conventional radiosurgery techniques. These faster treatments can be completed in minutes rather than the hours taken by conventional techniques and they can be carried out on lesions anywhere in the body, not just in the brain.”

According to Dr. Narain, the team at Kokilaben Hospital will use the Novalis Tx radiosurgery platform to perform radiosurgery and stereotactic radiotherapy for a number of indications, including lung, brain, liver, and prostate metastases, recurrent brain tumors, pituitary adenomas, acoustic neuromas, and meningiomas. "In particular it will help us to manage complex skull-base tumors and arteriovenous malformations with multimodality treatments, including stereotactic radiosurgery.”

The Novalis Tx radiosurgery platform features very high dose delivery rates, which contribute to shorter treatment times. It also provides dynamic fine beam-shaping and noninvasive, precise patient positioning for rapid and more comfortable treatments. Integrated imaging capabilities pinpoint the target before and during treatment and enable positioning of the patient with millimeter precision.

Kokilaben Hospital is a private center that treats approximately 3,000 new cancer patients each year from across India. Waiting lists are a major problem for cancer patients in India, and the speed and flexibility of the Novalis Tx radiosurgery platform will enable Kokilaben Hospital to treat more patients.

Ten Novalis Tx platforms have been ordered by Indian cancer centers in the two years since its introduction, making them among the most enthusiastic adopters of Novalis Tx technology to date.

Varian Medical Systems is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices.

BrainLAB develops, manufactures, and markets software-driven medical technology that enables procedures that are more precise, less invasive, and less expensive than traditional treatments. Among the core products are image-guided systems that provide highly accurate real-time information used for navigation during surgical procedures.

Related Links:
Varian Medical Systems
BrainLAB


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.